Treatment with atorvastatin attenuates progression of insulin resistance and pancreatic fibrosis in the Otsuka Long-Evans Tokushima fatty rats
详细信息    查看全文
文摘
The effects of statins on insulin resistance (IR) and type 2 diabetes mellitus (T2DM) are still controversial and its effects on pancreatic fibrosis are poorly defined. The purpose of this study is to examine the effects of atorvastatin on these issues using the Otsuka Long–Evans Tokushima Fatty (OLETF) rat, an animal model of IR, T2DM and pancreatic fibrosis.

d="absSec_2">Methods

d="sp0010">Male OLETF rats were divided into 2 groups at 6 weeks of age. The first group received a standard diet until the end of experimental period at age 28 weeks. The second group was given a diet containing 0.05% atorvastatin from 6 weeks of age, before the onset of IR and pancreatic fibrosis. The age-matched Long–Evans Tokushima Otsuka rats without presence of IR, T2DM and pancreatic fibrosis, received a standard diet and were used as a normal control.

d="absSec_3">Results

d="sp0015">Atorvastatin slightly decreased serum fasting glucose and insulin levels, but significantly improved index of IR compared with the untreated OLETF rats. In addition, atorvastatin markedly decreased transforming growth factor-β1 mRNA expression, myeloperoxidase activity and proportion of fibrotic area, and elevated superoxide dismutase activity in the pancreas compared with the untreated OLETF rats.

d="absSec_4">Conclusions

d="sp0020">These findings suggest that atorvastatin exerts favorable influence on progression of IR and pancreatic inflammation and fibrosis via pleiotropic effect such as anti-oxidative property.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700